Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Shares Bought by Barclays PLC

Barclays PLC grew its holdings in shares of Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) by 9.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 75,862 shares of the company’s stock after purchasing an additional 6,640 shares during the quarter. Barclays PLC’s holdings in Y-mAbs Therapeutics were worth $594,000 as of its most recent […]

Leave a Reply

Your email address will not be published.

Previous post Barclays PLC Acquires 3,399 Shares of Community West Bancshares (NASDAQ:CWBC)
Next post Barclays PLC Buys 11,876 Shares of Eastman Kodak (NYSE:KODK)